| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | $0.00 | $0.00 | $705.00K | $1.81M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $1.09B | $226.31M | $610.65M | $87.21M | $108.96M |
| R&D | $537.67M | $150.78M | $59.47M | $52.00M | $85.35M |
| SG&A | $556.75M | $60.53M | $30.27M | $26.74M | $23.61M |
| Operating Income | – | -$226.00M | -$609.65M | -$72.09M | -$86.19M |
| Interest Expense | – | – | $16.46M | $4.40M | $281.00K |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | $0.00 |
| Net Income | -$1.08B | -$221.31M | -$614.93M | -$78.78M | -$88.60M |
| EPS (basic) | -1.4400 | -0.3100 | -0.9900 | -0.4100 | -0.9600 |
| EPS (diluted) | -1.4400 | -0.3100 | -0.9900 | -0.4100 | -0.9600 |
| Shares (diluted) | $747.70M | $718.54M | $619.65M | $193.34M | $92.24M |